About
A pharmaceutical company developing therapies related to acute myocardial infarction (heart attack). The company is listed in Sarsia's life sciences portfolio focusing on treatments connected to restoration of blood supply after myocardial infarction.
Explore SERCA Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.